etoposide has been researched along with stilbenes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahyar-Roemer, M; Roemer, K | 1 |
| Lin, C; Liu, ZR; Yang, L | 1 |
| Bates, SE; Baumeister, P; Costa, F; Dong, D; Ko, B; Lee, AS; Markland, F; Patterson, JB; Stiles, C; Swenson, S | 1 |
| Ackermann, S; de Oliveira Franz, CB; Drews, G; Grenz, A; Hambrock, A; Hiller, S; Osswald, H; Schulze, DU | 1 |
| Hwang, JT; Kim, HM; Kim, YM; Kwak, DW; Lin, SK; Park, OJ | 1 |
| Bickenbach, KA; Kron, SJ; Mauceri, HJ; Posner, MC; Shao, MY; Veerapong, J; Weichselbaum, RR | 1 |
| Hu, Z; Ji, M; Ji, Y; Lin, Z; Lou, H; Wang, L; Wang, Y; Yuan, H | 1 |
| Bohndiek, SE; Booth, TC; Brindle, KM; Canuto, HC; Hobson, MP; Hu, DE; Kettunen, MI; Krishnan, AS; Larkin, TJ; McLachlan, C; Neves, AA | 1 |
| Amiri, F; Jeddi-Tehrani, M; Koohdani, F; Vafa, M; Zand, H; Zarnani, AH | 1 |
| Bigenzahn, J; Brunner, M; Heiduschka, G; Houben, R; Lill, C; Schmid, R; Seemann, R; Thurnher, D | 1 |
| Bigenzahn, J; Brunner, M; Heiduschka, G; Thurnher, D | 1 |
| Chang, PY; Chen, CY; Chen, JC; Jian, YJ; Jian, YT; Ko, JC; Lin, YW; Syu, JJ; Wang, TJ | 1 |
| Beck, JF; Becker, S; Blümel, L; Blumrich, A; Kahl, M; Krämer, OH; Siranjeevi, PM; Sonnemann, J; Winkler, R; Wittig, S | 1 |
| Cao, S; Chen, B; Sui, X; Tang, F; Wang, S; Xu, C; Yin, L; Zhang, C; Zhi, X; Zhou, J | 1 |
14 other study(ies) available for etoposide and stilbenes
| Article | Year |
|---|---|
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Blotting, Western; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Etoposide; HeLa Cells; Humans; Imatinib Mesylate; K562 Cells; Neoplasms; Paclitaxel; Phosphorus Radioisotopes; Phosphorylation; Piperazines; Precipitin Tests; Pyrimidines; RNA Helicases; RNA Interference; Stilbenes; Tumor Necrosis Factor-alpha | 2005 |
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Disintegrins; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; Female; Glucose; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Chaperones; Neovascularization, Pathologic; Oxygen; Promoter Regions, Genetic; RNA, Small Interfering; Stilbenes; Transcriptional Activation; Transfection; Xenograft Model Antitumor Assays | 2005 |
Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
Topics: Animals; Apoptosis; ATP-Binding Cassette Transporters; Caspases; Cell Adhesion; Cell Line; Etoposide; Female; Humans; Hypoglycemic Agents; Islets of Langerhans; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Recombinant Proteins; Resveratrol; Stilbenes; Sulfonylurea Receptors; Transfection | 2007 |
Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Resistance, Neoplasm; Etoposide; HT29 Cells; Humans; Multienzyme Complexes; Protein Serine-Threonine Kinases; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy.
Topics: Acetylation; Adenoviridae; Animals; Blotting, Western; Cell Line, Tumor; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Mice; Mice, Nude; Rats; Resveratrol; Sirtuins; Stilbenes; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2008 |
A novel derivative of riccardin D induces cell death through lysosomal rupture in vitro and inhibits tumor growth in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytoskeletal Proteins; Cytoskeleton; Etoposide; Humans; Inhibitory Concentration 50; Lysosomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Phenyl Ethers; Stilbenes; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Etoposide; Female; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasm Staging; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Stilbenes; Treatment Outcome | 2014 |
Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2013 |
The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Resveratrol; Stilbenes; Treatment Outcome | 2014 |
Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Reference Values; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2014 |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Transfection; X-ray Repair Cross Complementing Protein 1 | 2015 |
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Caspases; Cell Proliferation; Etoposide; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Sirtuin 1; Stilbenes; Tumor Cells, Cultured; Vincristine | 2016 |
Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Lymphoma, Extranodal NK-T-Cell; Mitochondria; Resveratrol; Stilbenes | 2017 |